These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 14747123)

  • 1. Pharmacokinetics of intravenous flucloxacillin and amoxicillin in neonatal and infant cardiopulmonary bypass surgery.
    Adrianzén Vargas MR; Danton MH; Javaid SM; Gray J; Tobin C; Brawn WJ; Barron DJ
    Eur J Cardiothorac Surg; 2004 Feb; 25(2):256-60. PubMed ID: 14747123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microanalysis of amoxicillin, flucloxacillin, and rifampicin in neonatal plasma.
    Pullen J; Stolk LM; Neef C; Zimmermann LJ
    Biomed Chromatogr; 2007 Dec; 21(12):1259-65. PubMed ID: 17604357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population pharmacokinetics and dosing of flucloxacillin in preterm and term neonates.
    Pullen J; de Rozario L; Stolk LM; Degraeuwe PL; van Tiel FH; Zimmermann LJ
    Ther Drug Monit; 2006 Jun; 28(3):351-8. PubMed ID: 16778719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of cefuroxime in infants and neonates undergoing cardiac surgery.
    Gertler R; Gruber M; Wiesner G; Grassin-Delyle S; Urien S; Tassani-Prell P; Martin K
    Br J Clin Pharmacol; 2018 Sep; 84(9):2020-2028. PubMed ID: 29761538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population pharmacokinetics and dosing of amoxicillin in (pre)term neonates.
    Pullen J; Stolk LM; Nieman FH; Degraeuwe PL; van Tiel FH; Zimmermann LJ
    Ther Drug Monit; 2006 Apr; 28(2):226-31. PubMed ID: 16628135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flucloxacillin dosing in critically ill patients with hypoalbuminaemia: special emphasis on unbound pharmacokinetics.
    Ulldemolins M; Roberts JA; Wallis SC; Rello J; Lipman J
    J Antimicrob Chemother; 2010 Aug; 65(8):1771-8. PubMed ID: 20530507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and bioavailability of flucloxacillin in elderly hospitalized patients.
    Gath J; Charles B; Sampson J; Smithurst B
    J Clin Pharmacol; 1995 Jan; 35(1):31-6. PubMed ID: 7751411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of free and total flucloxacillin in newborn infants.
    Herngren L; Ehrnebo M; Broberger U
    Eur J Clin Pharmacol; 1987; 32(4):403-9. PubMed ID: 3609118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amoxicillin pharmacokinetics in (preterm) infants aged 10 to 52 days: effect of postnatal age.
    Pullen J; Driessen M; Stolk LM; Degraeuwe PL; van Tiel FH; Neef C; Zimmermann LJ
    Ther Drug Monit; 2007 Jun; 29(3):376-80. PubMed ID: 17529898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lactate clearance in infants undergoing surgery for congenital heart disease.
    Desplanque L; Hamaide-Defrocourt F; Berkia I; Tourneur T; Albinni S; Bojan M
    Artif Organs; 2019 Jan; 43(1):54-59. PubMed ID: 30512202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vancomycin concentrations during cardiopulmonary bypass in pediatric cardiac surgery: a prospective study.
    Ferrari F; Benegni S; Marinari E; Haiberger R; Garisto C; Rizza A; Giorni C; Quattrone MG; Arpicco S; Muntoni E; Milla P; Ricci Z
    Perfusion; 2022 Sep; 37(6):553-561. PubMed ID: 33789546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue and plasma concentrations of cephuroxime during cardiac surgery in cardiopulmonary bypass--a microdialysis study.
    Mand'ák J; Pojar M; Maláková J; Lonsk V; Palicka V; Zivný P
    Perfusion; 2007 Mar; 22(2):129-36. PubMed ID: 17708162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetics of cefazolin before, during and after cardiopulmonary bypass in adult patients undergoing cardiac surgery.
    Asada M; Nagata M; Mizuno T; Uchida T; Takahashi H; Makita K; Arai H; Kijima S; Echizen H; Yasuhara M
    Eur J Clin Pharmacol; 2021 May; 77(5):735-745. PubMed ID: 33211137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of cardiopulmonary bypass on cefuroxime plasma concentration and pharmacokinetics in patients undergoing coronary surgery.
    Ferreira F; Santos S; Nascimento J; Strabelli T; Carmona M
    Eur J Cardiothorac Surg; 2012 Aug; 42(2):300-5. PubMed ID: 22290920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue and plasma concentrations of antibiotic during cardiac surgery with cardiopulmonary bypass--microdialysis study.
    Pojar M; Mandak J; Malakova J; Jokesova I
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2008 Jun; 152(1):139-45. PubMed ID: 18795089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of Prophylactic Ampicillin-Sulbactam and Dosing Optimization in Patients Undergoing Cardiovascular Surgery with Cardiopulmonary Bypass.
    Yokoyama Y; Matsumoto K; Ikawa K; Watanabe E; Yamamoto H; Imoto Y; Morikawa N; Takeda Y
    Biol Pharm Bull; 2015; 38(11):1817-21. PubMed ID: 26521833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum amoxicillin levels in young infants (0-59 days) with sepsis treated with oral amoxicillin.
    Mir F; Pearce RE; Baig-Ansari N; Qazi S; Barrett JS; Abdel-Rahman S; Kearns G; Zaidi AK
    Arch Dis Child; 2020 Dec; 105(12):1208-1214. PubMed ID: 32404437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alteration of vancomycin pharmacokinetics during cardiopulmonary bypass in patients undergoing cardiac surgery.
    Ortega GM; Martí-Bonmatí E; Guevara SJ; Gómez IG
    Am J Health Syst Pharm; 2003 Feb; 60(3):260-5. PubMed ID: 12613235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetics at two dose levels and pharmacodynamic profiling of flucloxacillin.
    Landersdorfer CB; Kirkpatrick CM; Kinzig-Schippers M; Bulitta JB; Holzgrabe U; Drusano GL; Sörgel F
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3290-7. PubMed ID: 17576847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone penetration of intravenous flucloxacillin and gentamicin as antibiotic prophylaxis during total hip and knee arthroplasty.
    Torkington MS; Davison MJ; Wheelwright EF; Jenkins PJ; Anthony I; Lovering AM; Blyth M; Jones B
    Bone Joint J; 2017 Mar; 99-B(3):358-364. PubMed ID: 28249976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.